Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,094,167 articles, preprints and more)

Anna Stengel

Visit ORCID profile

Publications
in ORCID

Publications
in Europe PMC

Free full text articles
in Europe PMC

Open citations
in Europe PMC

Want your own profile? Link your articles to your ORCID in 2 simple steps.

Publications listed in Europe PMC (6)

Sort by:

Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.
Hartmann L, Haferlach C, Meggendorfer M, Kern W, Haferlach T, Stengel A
Genes Chromosomes Cancer, 58(10):698-704, 01 May 2019
Cited by: 7 articles | PMID: 30994218
Detailed molecular analysis and evaluation of prognosis in cases with high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
Stengel A, Kern W, Meggendorfer M, Haferlach T, Haferlach C
Br J Haematol, 185(5):951-954, 20 Nov 2018
Cited by: 5 articles | PMID: 30460680
Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS.
Stengel A, Haferlach T, Baer C, Hutter S, Meggendorfer M, Kern W, Haferlach C
Blood Adv, 7(13):2952-2956, 01 Jul 2023
Cited by: 3 articles | PMID: 36735768 | PMCID: PMC10320211
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
No graph available until there is a citation in more than one year
How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing.
Müller J, Walter W, Haferlach C, Müller H, Fuhrmann I, Müller ML, Ruge H, Meggendorfer M, Kern W, Haferlach T, Stengel A
Leukemia, 37(1):217-221, 05 Nov 2022
Cited by: 3 articles | PMID: 36335263 | PMCID: PMC9883150
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
No graph available until there is a citation in more than one year
Impact of 9q deletions on the classification of patients with acute myeloid leukemia.
Balk B, Haferlach T, Meggendorfer M, Kern W, Haferlach C, Stengel A
J Cancer Res Clin Oncol, 145(11):2871-2874, 29 Mar 2019
Cited by: 2 articles | PMID: 30927073
No graph available until there is a citation in more than one year
Correction: How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing.
Müller J, Walter W, Haferlach C, Müller H, Fuhrmann I, Müller ML, Ruge H, Meggendorfer M, Kern W, Haferlach T, Stengel A
Leukemia, 37(1):252, 01 Jan 2023
Cited by: 0 articles | PMID: 36526738 | PMCID: PMC9883155
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

Search life-sciences literature (45,094,167 articles, preprints and more)

Anna Stengel

Publications listed in Europe PMC (6)

Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.

Detailed molecular analysis and evaluation of prognosis in cases with high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.

Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS.

How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing.

Impact of 9q deletions on the classification of patients with acute myeloid leukemia.

Correction: How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing.

Partnerships & funding